Sarah Vittori

2.3k total citations · 1 hit paper
5 papers, 782 citations indexed

About

Sarah Vittori is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Sarah Vittori has authored 5 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Hematology. Recurrent topics in Sarah Vittori's work include Protein Degradation and Inhibitors (4 papers), Ubiquitin and proteasome pathways (2 papers) and Multiple Myeloma Research and Treatments (1 paper). Sarah Vittori is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Ubiquitin and proteasome pathways (2 papers) and Multiple Myeloma Research and Treatments (1 paper). Sarah Vittori collaborates with scholars based in United States, Austria and Switzerland. Sarah Vittori's co-authors include James E. Bradner, Dennis L. Buckley, Justin M. Roberts, Kwok‐Kin Wong, Shiva Dastjerdi, Annan Yang, Georg Winter, Matthew A. Lawlor, Jun Qi and Thomas G. Scott and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Nature Chemical Biology.

In The Last Decade

Sarah Vittori

5 papers receiving 776 citations

Hit Papers

The dTAG system for immediate and target-specific protein... 2018 2026 2020 2023 2018 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Vittori United States 5 725 164 92 48 41 5 782
Wassim Abdulrahman France 7 666 0.9× 183 1.1× 109 1.2× 30 0.6× 45 1.1× 9 722
Kathy A. Gelato Germany 14 739 1.0× 92 0.6× 135 1.5× 31 0.6× 59 1.4× 21 815
Ann Katrin Greifenberg Germany 7 641 0.9× 267 1.6× 60 0.7× 45 0.9× 30 0.7× 8 762
Christian A. Bösken Germany 6 597 0.8× 256 1.6× 53 0.6× 49 1.0× 21 0.5× 6 706
Oscar W. Huang United States 8 566 0.8× 144 0.9× 37 0.4× 41 0.9× 66 1.6× 8 614
Wanyi Hu United States 8 387 0.5× 180 1.1× 72 0.8× 26 0.5× 25 0.6× 19 439
Siddhartha Sen United States 11 284 0.4× 106 0.6× 93 1.0× 90 1.9× 17 0.4× 15 410
Corinna Wieshofer Austria 3 481 0.7× 116 0.7× 107 1.2× 20 0.4× 16 0.4× 4 508
Thang Van Nguyen United States 9 477 0.7× 194 1.2× 63 0.7× 100 2.1× 28 0.7× 12 581
Anne Mirabella United States 5 354 0.5× 158 1.0× 51 0.6× 12 0.3× 52 1.3× 6 432

Countries citing papers authored by Sarah Vittori

Since Specialization
Citations

This map shows the geographic impact of Sarah Vittori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Vittori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Vittori more than expected).

Fields of papers citing papers by Sarah Vittori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Vittori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Vittori. The network helps show where Sarah Vittori may publish in the future.

Co-authorship network of co-authors of Sarah Vittori

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Vittori. A scholar is included among the top collaborators of Sarah Vittori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Vittori. Sarah Vittori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Skucha, Anna, Mareike Roth, Thomas Eder, et al.. (2018). MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. Nature Communications. 9(1). 1983–1983. 43 indexed citations
2.
Nabet, Behnam, Justin M. Roberts, Dennis L. Buckley, et al.. (2018). The dTAG system for immediate and target-specific protein degradation. Nature Chemical Biology. 14(5). 431–441. 652 indexed citations breakdown →
3.
Koo, Seong Joo, Amaury E. Fernández‐Montalván, Volker Badock, et al.. (2016). ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication. Oncotarget. 7(43). 70323–70335. 61 indexed citations
4.
Koblan, Luke W., Dennis L. Buckley, Christopher J. Ott, et al.. (2016). Assessment of Bromodomain Target Engagement by a Series of BI2536 Analogues with Miniaturized BET‐BRET. ChemMedChem. 11(23). 2575–2581. 12 indexed citations
5.
Soukup, Klara, Angela Halfmann, Emine Sahin, et al.. (2015). The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell–Mediated Th1 Differentiation and Autoimmune Encephalomyelitis. The Journal of Immunology. 195(2). 541–552. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026